Rituximab as a rescue therapy in patients with glomerulonephritis

To evaluate the use of rituximab in the treatment of severe glomerulonephritis (GN) in order to prevent progression of kidney disease toward the end stage, we designed a multicenter, retrospective study in Saudi Arabia about the efficacy and safety of the use of "off label" rituximab in a...

Full description

Bibliographic Details
Main Authors: Muhammad Ziad Souqiyyeh, Faissal A. M. Shaheen, Abdulkareem Alsuwaida, Mohammed Alghonaim, Jamal Alwakeel, Dujana Mosa, Faheem Akhtar, Ebadur Rahman, Maged Hussein, Hysam Roujouleh, Nauman Siddiqi, Ibtissam Bukhari, Nihal Sadaqa, Faissal Mushtaque, Neveen Mustafa Awn, Fouad Shariya, Adnan Alfi, Mohammad Amin, Mustafa Ahmad, Fadel Abbas Rowaie, Samir Almueilo, Mohamed Chihab Eddine Kechrid, Ayman Karkar
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2015-01-01
Series:Saudi Journal of Kidney Diseases and Transplantation
Online Access:http://www.sjkdt.org/article.asp?issn=1319-2442;year=2015;volume=26;issue=1;spage=47;epage=55;aulast=Souqiyyeh

Similar Items